In Croatia, the validity of covid certificates has been extended to one year

ECDC draws attention to the risks of loosening measures against sufficient vaccination The European Center for Disease Control and Prevention (ECDC) warns against an increase in new coronavirus infections in the autumn in countries where vaccination levels are not yet sufficient, especially in the event of the release of restrictive measures. In total, 61.1 percent of the total population of the EU, Norway, Iceland and Liechtenstein have been vaccinated, they said today. Countries with a vaccination rate at or below the European average and intending to ease measures in the next two weeks are expected to see a significant increase in infections, hospital admissions and deaths by the end of November, the German news agency dpa said in a report. ECDC. “Forecasts suggest that a combination of high vaccination coverage and effective contact restraint is key to reducing the risk of covid-19 health system strain this autumn, “ was written in the message by the director of ECDC Andrea Ammon . She added that countries should work to step up vaccination in all age groups to prevent the spread of the delta version in the coming months. Depending on the situation in each country, restrictive measures may be needed until the end of November. So far, only Malta, Portugal and Iceland have fully vaccinated more than 75 percent of the population against covid-19. In Slovenia, about 53 percent of the population is vaccinated with one dose of the covid-19 vaccine, and about 47 percent with all doses of the vaccine. The European Union will extend the mechanism for controlling the export of vaccines The European Union will extend the mechanism for controlling the export of covid-19 vaccines for another three months and will then replace it with the so-called monitoring mechanism, the European Commission announced today. Brussels introduced the measure at the beginning of the year due to problems with the supply of vaccines, and its extension is linked to uncertainty due to new versions of the virus. According to the commission, the mechanism will be extended until December 31, because uncertainties remain, especially with the emergence of new versions of the new coronavirus. On 1 January, however, they intend to introduce a “monitoring mechanism to ensure timely data on company-specific vaccine exports”. At the end of January, the European Commission set up a mechanism to ensure transparency in the export of vaccines in response to problems with the supply of vaccines against covid-19. Under the mechanism, producers of vaccines produced in the EU must obtain an appropriate authorization before exporting from a link. The mechanism allows in certain cases to ban the export of the vaccine if the company does not fulfill its contractual obligations to the EU. The measure has been extended several times in the meantime, and the last extension expires today. Brussels introduced the mechanism at the beginning of the introduction of vaccination in the EU, which was initially slow due to the large shortage of vaccine doses promised by the British-Swedish company AstraZeneca. They were angry in Brussels because the company supplied a relatively large amount of vaccine to the UK, where AstraZeneca is based, even though some doses were produced in the European Union.